Skip to search formSkip to main contentSkip to account menu

Cancer Vaccines

Known as: vaccines cancer, Tumor Vaccine, Cancer Vaccines [Chemical/Ingredient] 
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Despite the tremendous potential of peptide-based cancer vaccines, their efficacy has been limited in humans. Recent innovations… 
Review
2014
Review
2014
The therapeutic potential of host-specific and tumour-specific immune responses is well recognized and, after many years, active… 
Highly Cited
2012
Highly Cited
2012
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs… 
Review
2007
Review
2007
  • E. Gilboa
  • The Journal of clinical investigation
  • 2007
  • Corpus ID: 36402322
Because of the large preexisting antigenic load and immunosuppressive environment within a tumor, inducing therapeutically useful… 
Review
2005
Review
2005
Cancer/testis (CT) antigens, of which more than 40 have now been identified, are encoded by genes that are normally expressed… 
Highly Cited
2005
Highly Cited
2005
Unmet needs across the oncology market remain high, with most traditional therapies representing a trade-off between levels of… 
Highly Cited
2004
Highly Cited
2004
Great progress has been made in the field of tumor immunology in the past decade, but optimism about the clinical application of… 
Review
2004
Review
2004
The problem with pure recombinant or synthetic antigens used in modern day vaccines is that they are generally far less… 
Review
2003
Review
2003
  • O. Finn
  • Nature Reviews Immunology
  • 2003
  • Corpus ID: 6861735
Whether vaccines are designed to prepare the immune system for the encounter with a pathogen or with cancer, certain common… 
Highly Cited
1994
Highly Cited
1994
Many tumors express tumor-specific antigens capable of being presented to CD8+ T cells by major histocompatibility complex (MHC…